Skip to main content
SpringerLink
Log in

Synthesis of novel (2,3-dihydro-1,4-thiaselenin-2-yl)sulfanyl-substituted pharmacophoric nitrogen heterocycles based on 2-(bromomethyl)-1,3-thiaselenole

  • Published:
Chemistry of Heterocyclic Compounds Aims and scope

A new method for regioselective nucleophilic substitution at one of the three possible reaction centers of seleniranium cation, generated from 2-(bromomethyl)-1,3-thiaselenole, with mono- and bicyclic nitrogen-containing heteroaromatic thiols was developed. The reaction was directed at the carbon atom attached to sulfur atom of the intermediate seleniranium cation and was accompanied by rearrangement with ring expansion to afford in high yields new (2,3-dihydro-1,4-thiaselenin-2-yl)sulfanyl-substituted pharmacophoric heterocycles with one to four nitrogen atoms. The reaction of 2-(bromomethyl)-1,3-thiaselenole and quinoxaline-2,3-dithiol provided the corresponding 2,3-bis[(2,3-dihydro-1,4-thiaselenin-2-yl)sulfanyl] derivative. In the case of 5-methyl-1,3,4-thiadiazole-2-thiol, the reaction in MeCN led to 2-methyl-5-{[(1,3-thiaselenol-2-yl)methyl]sulfanyl}-1,3,4-thiadiazole at the expense of rearrangement of the intermediate (2,3-dihydro-1,4-thiaselenin-2-yl)sulfanyl derivative in a form of hydrobromide salt with the ring contraction proceeding via seleniranium cation. The synthesized novel sulfur- and selenium-containing functionalized unsaturated heterocycles can be considered as potential scaffolds for medicinal chemistry.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. (a) Singh, F. V.; Wirth, T. In Physical Sciences Reviews; Giamberini, M.; Jastrzab, R.; Liou, J. J.; Luque, R.; Nawab, Y.; Saha, B.; Tylkowski, B.; Xu, C.-P.; Cerruti, P.; Ambrogi, V.; Marturano, V.; Gulaczyk, I., Eds.; Walter de Gruyter: Berlin, Boston, 2018, Vol. 4, p. 20170131. (b) Chivers, T.; Laitinen, R. S. In Physical Sciences Reviews; Giamberini, M.; Jastrzab, R.; Liou, J. J.; Luque, R.; Nawab, Y.; Saha, B.; Tylkowski, B.; Xu, C.-P.; Cerruti, P.; Ambrogi, V.; Marturano, V.; Gulaczyk, I., Eds.; Walter de Gruyter: Berlin, Boston, 2018, Vol. 3, p. 20180060. (c) Lenardão, E. J.; Santi, C.; Sancineto, L. New Frontiers in Organoselenium Compounds; Springer: Heidelberg, 2018. (d) Santi, C.; Santoro, S. In Organoselenium Chemistry: Synthesis and Reactions; Wirth, T., Ed.; Wiley-VCH: Weinheim, 2011, p. 1. (e) Freudendahl, D. M.; Wirth, T. In Selenium and Tellurium Chemistry. From Small Molecules to Biomolecules and Materials; Woollins, J. D.; Laitinen, R. S., Eds.; Springer-Verlag: Heidelberg, 2011, p. 41. (f) Dutton, J. L.; Ragogna, P. J. In Selenium and Tellurium Chemistry. From Small Molecules to Biomolecules and Materials; Woollins, J. D.; Laitinen, R. S., Eds.; Springer-Verlag: Heidelberg, 2011, p. 179. (g) Browne, D. M.; Niyomura, O.; Wirth, T. Org. Lett.2007, 9, 3169. (h) Denmark, S. E.; Collins, W. R.; Cullen, M. D. J. Am. Chem. Soc.2009, 131, 3490. (i) Gabriele, E.; Singh, F. V.; Freudendahl, D. M.; Wirth, T. Tetrahedron2012, 68, 10573. (j) Freudendahl, D. M.; Iwaoka, M.; Wirth, T. Eur. J. Org. Chem.2010, 3934. (k) Ścianowski, J.; Rafiński, Z. In Organoselenium Chemistry: Between Synthesis and Biochemistry; Santi, C., Ed.; Bentham Science Publishers: Sharjah, 2014, p. 8. (l) Cox, M.; Wirth, T. Phosphorus, Sulfur Silicon Relat. Elem.2005, 180, 659.

  2. (a) Potapov, V. A.; Amosova, S. V.; Belozerova, O. V.; Albanov, A. I.; Yarosh, O. G.; Voronkov, M. G. Chem. Heterocycl. Compd.2003, 39, 549. [Khim. Geterotsikl. Soedin.2003, 633.] (b) Potapov, V. A.; Amosova, S. V. Russ. J. Org. Chem.2003, 39, 1373. [Zh. Org. Khim.2003, 39, 1449.]

  3. (a) Potapov, V. A.; Musalov, M. V.; Musalova, M. V.; Amosova, S. V. Curr. Org. Chem.2016, 20, 136. (b) Abakumov, G. A.; Piskunov, A. V.; Cherkasov, V. K.; Fedushkin, I. L.; Ananikov, V. P.; Eremin, D. B.; Gordeev, E. G.; Beletskaya, I. P.; Averin, A. D.; Bochkarev, M. N.; Trifonov, A. A.; Dzhemilev, U. M.; Dyakonov, V. A.; Egorov, M. P.; Vereshchagin, A. N.; Syroeshkin, M. A.; Jouikov, V. V.; Muzafarov, A. M.; Anisimov, A. A.; Arzumanyan, A. V.; Kononevich, Yu. N.; Temnikov, M. N.; Synyashin, O. G.; Budnikova, Yu. H.; Burilov, A. R.; Karasik, A. A.; Mironov, V. F.; Storozhenko, P. A.; Shcherbakova, G. I.; Trofimov, B. A.; Amosova, S. V.; Gusarova, N. K.; Potapov, V. A.; Shur, V. B.; Burlakov, V. V.; Bogdanov, V. S.; Andreev, M. V. Russ. Chem. Rev.2018, 87, 393. [Usp. Khim.2018, 87, 393.]

  4. Amosova, S. V.; Penzik, M. V.; Albanov, A. I.; Potapov, V. A. Tetrahedron Lett.2009, 50, 306.

    Article  CAS  Google Scholar 

  5. (a) Amosova, S. V.; Novokshonova, I. A.; Penzik, M. V.; Filippov, A. S.; Albanov, A. I.; Potapov, V. A. Tetrahedron Lett.2017, 58, 4381. (b) Amosova, S. V.; Penzik, M. V.; Potapov, V. A.; Filippov, A. S.; Shagun, V. A.; Albanov, A. I.; Borodina, T. N.; Smirnov, V. I. Synlett2016, 1653.

  6. (a) Amosova, S. V.; Filippov, A. S.; Potapov, V. A.; Penzik, M. V.; Makhaeva, N. A.; Albanov, A. I. Synthesis2019, 1832. (b) Amosova, S. V.; Filippov, A. S.; Makhaeva, N. A.; Albanov, A. I.; Potapov, V. A. New J. Chem.2019, 43, 11189. (c) Amosova, S. V.; Filippov, A. S.; Potapov, V. A.; Makhaeva, N. A.; Albanov, A. I. Russ. J. Org. Chem.2018, 54, 1697. [Zh. Org. Khim.2018, 54, 1682.]

  7. Amosova, S. V.; Penzik, M. V.; Rykunova, Yu. I.; Potapov, V. А.; Albanov, А. I. Russ. J. Org. Chem.2017, 53, 1691. [Zh. Org. Khim.2017, 53, 1655.]

  8. (a) Lukevits, E. Chem. Heterocycl. Compd.1995, 31, 639. [Khim. Geterotsikl. Soedin. 1995, 723.] (b) Tolba, M. S.; Kamal El-Dean, A. M.; Ahmed, M.; Hassanien, R. J. Chin. Chem. Soc.2019, 66, 548. b Jampilek, J. Curr. Med. Chem.2014, 21, 4347. c Azev, Yu. A.; Koptyaeva, O. S.; Tsmokalyuk, A. N.; Pospelova, T. A.; Gerasimova, N. A.; Evstigneeva, N. P.; Zil'berberg, N. V.; Kungurov, N. V.; Chupakhin, O. N. Chem. Nat. Compd.2019, 55, 513. [Khim. Prir. Soedin. 2019, 441.]

  9. (a) Singh, R.; Chouhan, A. World J. Pharm. Pharm. Sci.2014, 3, 574. (b) Arunachalam, S.; Gowrishankar, N. L.; Krishnan, A.; Akhileswaran, A.; Tindu, K. D. World J. Pharm. Pharm. Sci.2017, 6, 436. (c) Patil, S. B. Int. J. Pharm. Sci. Res.2018, 9, 44. (d) Jain, K. S.; Arya, N.; Inamdar, N. N.; Auti, P. B.; Unawane, S. A.; Puranik, H. H.; Sanap, M. S.; Inamke, A. D.; Mahale, V. J.; Prajapati, C. S.; Shishoo, C. J. Curr. Top. Med. Chem.2016, 16, 3133.

  10. (a) Solomon, V. R.; Lee, H. Curr. Med. Chem.2011, 18, 1488. (b) Jhanwar, D.; Sharma, J. Int. J. Pharm. Res. Bio-Sci.2015, 4, 130.

  11. (a) Pinheiro, A. C.; Mendonça Nogueira, T. C.; de Souza, M. V. N. Anti-Cancer Agents Med. Chem.2016, 16, 1339. (b) Irfan, A.; Sabeeh, I.; Umer, M.; Naqvi, A. Z.; Fatima, H.; Yousaf, S.; Fatima, Z. World J. Pharm. Res.2017, 6, 47. (c) El Newahie, A. M. S.; Nissan, Y. M.; Ismail, N. S. M.; El Ella, D. A. A; Khojah, S. M; Abouzid, K. A. M. Molecules2019, 24, 1175/1.

  12. (a) Khalilullah, H.; Khan, M. U.; Mahmood, D.; Akhtar, J.; Osman, G. Int. J. Pharm. Pharm. Sci.2014, 6, 8. (b) Kalidhar, U; Kaur, A. Res. J. Pharm., Biol. Chem. Sci.2011, 2, 1091. (c) Raj, V.; Rai, A.; Saha, S. Anti-Cancer Agents Med. Chem.2017, 17, 500.

  13. (a) Ostrovskii, V. A.; Trifonov, R. E.; Popova, E. A. Russ. Chem. Bull., Int. Ed.2012, 61, 768. [Izv. Akad. Nauk, Ser. Khim.2012, 765]. (b) Kaushik, N.; Kumar, N.; Kumar, A.; Singh, U. K. Immunol. Endocr. Metab. Agents Med. Chem.2018, 18, 3.

  14. Bildziukevich, U.; Rárová, L.; Šaman, D.; Wimmer, Z. Eur. J. Med. Chem.2018, 145, 41.

    Article  CAS  Google Scholar 

  15. (a) Joshi, S. D.; Jangade, N. M.; Dixit, S. R.; Joshi, A. S.; Kulkarni, V. H. Indo Am. J. Pharm. Res.2016, 6, 5033. (b) Atwell, G. J.; Baguley, B. C.; Denny, W. A. J. Med. Chem.1989, 32, 396.

  16. Singh, R.; Chouhan, A. World J. Pharm. Pharm. Sci.2014, 3, 574.

    Google Scholar 

  17. (a) Myznikov, L. V.; Hrabalek, A.; Koldobskii, G. I. Chem. Heterocycl. Compd.2007, 43, 1. [Khim. Geterotsikl. Soedin. 2007, 3.] (b) Gao, C.; Chang, L.; Xu, Z.; Yan, X.-F.; Ding, C.; Zhao, F.; Wu, X.; Feng, L.-S. Eur. J. Med. Chem.2019, 163, 404.

  18. (a) Mugesh, G.; du Mont, W.-W.; Sies, H. Chem. Rev.2001, 101, 2125.(b) Nogueira, C. W.; Zeni, G.; Rocha, J. B. T. Chem. Rev.2004, 104, 6255. (c) Soriano-Garcia, M. Curr. Med. Chem.2004, 11, 1657. (d) Nogueira, C. W.; Rocha, J. B. T. Arch. Toxicol.2011, 85, 1313. (e) Sanmartín, C.; Plano, D.; Sharma, A. K.; Palop, J. A. Int. J. Mol. Sci.2012, 13, 9649. (f) May, S. W. In Topics in Medicinal Chemistry; Schwarz, J., Ed.; Springer: Cham, 2016, Vol. 17, p. 87. (g) Banerjee, B.; Koketsu, M. Coord. Chem. Rev.2017, 339, 104. (h) Elsherbini, M.; Hamama, W. S.; Zoorob, H. H. Coord. Chem. Rev.2016, 312, 149. (i) Ninomiya, M.; Garud, D. R.; Koketsu, M. Coord. Chem. Rev.2011, 255, 2968. (j) Naithani, R. Mini-Rev. Med. Chem.2008, 8, 657. (k) Sancineto, L.; Mariotti, A.; Bagnoli, L.; Marini, F.; Desantis, J.; Iraci, N.; Santi, C.; Pannecouque, C.; Tabarrini, O. J. Med. Chem.2015, 58, 9601. (l) Bartolini, D.; Sancineto, L.; de Bem, A. F.; Tew, K. D.; Santi, C.; Radi, R.; Toquato, P.; Galli, F. In Advances in Cancer Research; Tew, K. D.; Galli, F., Eds.; Elsevier: New York, 2017, Vol. 136, p. 259. (m) Wirth, T. Angew. Chem., Int. Ed.2015, 54, 10074. (n) Fonseca, S. F.; Lima, D. B.; Alves, D.; Jacob, R. G.; Perin, G.; Lenardão, E. J.; Savegnago, L. New J. Chem.2015, 39, 3043. (o) Iwaoka, M.; Arai, K. Curr. Chem. Biol.2013, 7, 2.

  19. (a) Saito, I.; Asano, T.; Sano, K.; Takakura, K.; Abe, H.; Yoshimoto, T.; Kikuchi, H.; Ishibashi, S. Neurosurgery1998, 42, 269. (b) Yamaguchi, T.; Sano, K.; Takakura, K.; Saito, I.; Shinohara, Y.; Asano, T.; Yasuhara, H. Stroke1998, 29, 12.

  20. Duddeck, H. Prog. Nucl. Magn. Reson. Spectrosc.1995, 27, 1.

    Article  CAS  Google Scholar 

  21. PASS, Version 2.0; Way2Drug: Moscow, 2011.

Download references

The work was performed using the material and technical base of the Baikal Analytical Center for Collective Use, Siberian Branch of the Russian Academy of Sciences.

Author information

Authors and Affiliations

  1. A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 1 Favorsky St, Irkutsk, 664033, Russia

    Svetlana V. Amosova, Alexander V. Martynov, Alexander I. Albanov & Vladimir A. Potapov

Authors
  1. Svetlana V. Amosova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander V. Martynov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander I. Albanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vladimir A. Potapov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Svetlana V. Amosova.

Additional information

Published in Khimiya Geterotsiklicheskikh Soedinenii, 2020, 56(2), 226–232

Electronic supplementary material

ESM 1

(PDF 1906 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amosova, S.V., Martynov, A.V., Albanov, A.I. et al. Synthesis of novel (2,3-dihydro-1,4-thiaselenin-2-yl)sulfanyl-substituted pharmacophoric nitrogen heterocycles based on 2-(bromomethyl)-1,3-thiaselenole. Chem Heterocycl Comp 56, 226–232 (2020). https://doi.org/10.1007/s10593-020-02648-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10593-020-02648-x

Keywords

Search

Navigation